Compare PRAX & REYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | REYN |
|---|---|---|
| Founded | 2015 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.7B |
| IPO Year | 2020 | 2019 |
| Metric | PRAX | REYN |
|---|---|---|
| Price | $305.51 | $25.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 6 |
| Target Price | ★ $572.13 | $24.83 |
| AVG Volume (30 Days) | 329.6K | ★ 1.1M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.47% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.28 |
| Revenue | N/A | ★ $3,756,000,000.00 |
| Revenue This Year | N/A | $1.91 |
| Revenue Next Year | $7,758.26 | $1.82 |
| P/E Ratio | ★ N/A | $89.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.25 | $20.44 |
| 52 Week High | $366.52 | $27.32 |
| Indicator | PRAX | REYN |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 45.03 |
| Support Level | $284.87 | $23.62 |
| Resistance Level | $331.21 | $26.25 |
| Average True Range (ATR) | 16.88 | 0.63 |
| MACD | -2.16 | -0.23 |
| Stochastic Oscillator | 34.34 | 19.31 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.